Amphastar Pharmaceuticals Inc expected to post earnings of 91 cents a share - Earnings Preview

Amphastar Pharmaceuticals,

26/02/2024 21:33

* Amphastar Pharmaceuticals Inc  AMPH.OQ   AMPH.O  is
expected
to show a rise in quarterly revenue when it reports  results on
February 28 for the period ending December 31 2023
    * The Rancho Cucamonga California-based  company is expected
to
report a 30.1% increase in revenue to $175.666 million from
$135.02 million a year ago, according to the mean estimate from
5 analysts, based on LSEG data. (Majority is on Total revenue
basis)
    * ​LSEG's mean analyst estimate for Amphastar
Pharmaceuticals Inc
is for earnings of 91 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $68.00​, above​ its last closing price
of $53.41. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  0.70        0.69       1.15      Beat    65.5
 Jun. 30 2023  0.56        0.56       0.65      Beat    16
 Mar. 31 2023  0.47        0.48       0.62      Beat    30.4​
 Dec. 31 2022  0.40        0.41       0.73      Beat    79.7
 ​​Sep.        0.40        0.39       0.38      Missed  -3.6
 30 2022                                                
 Jun. 30 2022  0.35        0.35       0.39      Beat    12.1​
 Mar. 31 2022  0.36        0.36       0.47      Beat    30.6
 Dec. 31 2021  0.33        0.36       0.42      Beat    16.1
 This summary was machine generated February 26 at 21:33 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)